Clinical trial NCT05044819
Status: Active, not recruitingPhase 4Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
- Record number
- NCT05044819
- Status
- Active, not recruiting
- Type and phase
- Clinical trial, phase 4
- Participants
- 154 (actual)
- Condition (as registered)
- Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex
- Countries
- United States
- Topic in the guide
- Dravet Syndrome, Lennox–Gastaut Syndrome, Tuberous Sclerosis
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: July 7, 2021
- End of data collection for primary results: August 1, 2027 (expected)
- Trial completion: March 31, 2028 (expected)
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Active, not recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Dravet Syndrome: ongoing trials · Lennox–Gastaut Syndrome: ongoing trials · Tuberous Sclerosis: ongoing trials · Thinking of taking part? Which specialist to see